We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04659811
Brief Title: Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

First Submitted : November 30, 2020
First Submitted that Met QC Criteria : December 2, 2020
First Posted : December 9, 2020

Last Update Submitted that Met QC Criteria : October 28, 2022
Last Update Posted : November 1, 2022